Hiromi Kitao

Bortezomib-cyclophosphamide-dexamethasone induction/consolidation and bortezomib maintenance for transplant-eligible newly diagnosed multiple myeloma: phase 2 multicenter trial

H. Ohno, J. Kanda, T. Nakayama, 2022, Hematology.

Long-term effects of antihypertensive therapy on cardiovascular events and new-onset diabetes mellitus in high-risk hypertensive patients in Japan

K. Ueshima, K. Oba, S. Yasuno, 2018, Journal of hypertension.